share_log

【変更報告書】ハイツ・キャピタル・マネジメント・インク、シンバイオ製薬(4582.JP)株の保有割合を4.18%に減少と報告

Insider decrases its stake in SymBio Pharmaceuticals(4582.JP) to 4.18%

Moomoo News ·  Jul 25 02:24

On Jul 25, ハイツ・キャピタル・マネジメント・インク submitted the Change Report to Ministry of Finance. The report shows that ハイツ・キャピタル・マネジメント・インク decreased their holdings in $SymBio Pharmaceuticals (4582.JP)$, with their joint shareholding ratio down from 7.22% to 4.18%, below 5%.

JPStockInsiderTradingAutoNewsSpider_mm_S100U2YX_1721888640_en-us

Source: Edinet Announcement

What is the 5% shareholding reporting system?

Shareholders with holding ratio exceeding 5% must submit a Large Shareholding Report within five business days from that day. If the holding ratio increases or decreases by 1% or more after submitting a Large Shareholding Report, the holder must submit a Change Report within five business days from that day.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment